Aldeyra Therapeutics's market cap is currently $400.17M. The company's EPS TTM is $-0.753; its P/E ratio is ―; Aldeyra Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -262.78K	$ -258.71K	$ -264.18K	$ -56.22K	$ -96.31K
Operating Income	$ -42.79M	$ -62.68M	$ -56.22M	$ -36.42M	$ -63.07M
EBITDA	$ -35.21M	$ -60.07M	$ -55.77M	$ -36.07M	$ -61.44M
Net Income	$ -37.54M	$ -61.37M	$ -59.25M	$ -37.55M	$ -60.83M
Balance Sheet
Cash & Short-Term Investments	$ 142.82M	$ 174.30M	$ 229.79M	$ 77.86M	$ 73.36M
Total Assets	$ 148.33M	$ 181.29M	$ 233.14M	$ 83.35M	$ 75.52M
Total Debt	$ 15.66M	$ 16.08M	$ 15.86M	$ 15.33M	$ 14.75M
Net Debt	$ -127.17M	$ -128.34M	$ -213.93M	$ -62.53M	$ -29.67M
Total Liabilities	$ 28.53M	$ 30.28M	$ 27.40M	$ 23.84M	$ 27.44M
Stockholders' Equity	$ 119.80M	$ 151.01M	$ 205.74M	$ 59.51M	$ 48.08M
Cash Flow
Free Cash Flow	$ -30.33M	$ -56.65M	$ -42.56M	$ -37.49M	$ -44.99M
Operating Cash Flow	$ -30.33M	$ -56.64M	$ -42.56M	$ -37.49M	$ -44.98M
Investing Cash Flow	$ 30.00M	$ -29.95M	$ -7.81K	$ 29.02M	$ 18.48M
Financing Cash Flow	$ -1.27M	$ 1.22M	$ 194.50M	$ 41.90M	$ 23.58M

Currency in USD

Aldeyra Therapeutics Earnings and Revenue History

Income Statement >

Aldeyra Therapeutics Debt to Assets

Balance Sheet >

Aldeyra Therapeutics Cash Flow

Cash Flow >

Aldeyra Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing